Form D · Other Health Care
Rodin Therapeutics, Inc.
Cambridge, MA · CIK 0001716694
Offering snapshot reported Sep 14, 2017 · SEC filing
- Reported sold
- $10.8M Offering amount: $27.1M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 30, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2017 | Initial | $10,826,792 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-294765
Source: Form D, filed Sep 14, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kees Been | Director |
| Bruce Booth | Director |
| Adam Rosenberg | Director, Executive |
| Samantha Singer | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
300 Technology Square 8 Th Floor
Cambridge, MA, 02139
Cambridge, MA, 02139